By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > Policy & Systems > Quality & Safety > FDA Issues Early Alert for Abiomed Catheter Kit Linked to Blood Clot Formation
Policy & SystemsQuality & Safety

FDA Issues Early Alert for Abiomed Catheter Kit Linked to Blood Clot Formation

GMJ
Last updated: 06/06/2026 01:03
By
GMJ Policy Desk
Share
5 Min Read
Medical catheter device with FDA safety warning symbol
FDA warns that prolonged use of Abiomed 14Fr Low Profile Introducer catheter may cause blood clot formation. Healthcare providers advised to enhance monitoring protocols. — Photo: www.kaboompics.com / Pexels
SHARE
🎧 Listen to this article2:46 min · 377 words · GMJ Audio
2 min read|377 words
✓ Reviewed by Prof. Giorgi Pkhakadze, MD, MPH, PhD · ORCID 0000-0001-7609-4515

🟠 Moderate Evidence

Contents
    • Key takeaways
  • Safety Alert Details
  • Clinical Implications
  • Device Information
    • What this means
  • Frequently asked questions
    • What is the Abiomed 14Fr Low Profile Introducer?
    • What is the main concern?
    • Where can I find more information?

The US Food and Drug Administration has issued an early safety alert for the Abiomed 14Fr Low Profile Introducer catheter kit, warning that prolonged use may lead to dangerous blood clot formation, according to the FDA alert.

Key takeaways

  • FDA warns prolonged use of Abiomed 14Fr Low Profile Introducer may cause thrombus formation
  • The device is a catheter kit used for vascular access procedures
  • This information comes from an official FDA early alert
14Fr
diameter of affected Low Profile Introducer catheter kit

Safety Alert Details

The FDA’s early alert system identified potential complications associated with the Abiomed 14Fr Low Profile Introducer when used for extended periods. The catheter kit is used in cardiac procedures requiring vascular access for mechanical circulatory support devices.

According to the FDA alert, thrombus formation represents a serious complication that can develop with prolonged use of this device.

Submit Your Paper
GMJ_Submit_Banner
🎙️ Related Podcast Episodes
🎧 #37 | GMJ Podcast | NAD⁺ Injections and “NAD Boosters” — Public Health Risks and Regulatory Implications · 20m
🎧 #32 | GMJ Podcast | Launch of the Georgian Medical Journal — A New International Platform for Medical Science · 5m
🎧 #28 | GMJ Podcast | SheniEkimi.ge #1: Top 5 Evidence-Based Public Health News · 19m
🎧 #20 | WHO: Conflict and Instability Make Pregnancy More Dangerous · 18m
🎧 #15 | WHO: One in Two People Facing Cataract Blindness Still Need Access to Surgery · 21m

Clinical Implications

The FDA alert indicates that prolonged catheterization with the 14Fr Low Profile Introducer increases thrombus formation risk. Healthcare providers must consider the duration of device use when implementing this catheter kit in patient care.

Prolonged use of the Abiomed 14Fr Low Profile Introducer may lead to thrombus formation

— FDA Medical Device Early Alert

Device Information

The FDA has identified this issue through its medical device surveillance system. The Abiomed 14Fr Low Profile Introducer is a catheter kit used to provide vascular access for cardiac support procedures.

What this means

For patients: Those receiving cardiac support devices should be aware of potential complications with extended catheter use
For clinicians: Healthcare providers should consider the risks associated with prolonged use of this specific catheter kit
For policymakers: The FDA early alert system provides important safety communications for medical devices

Frequently asked questions

What is the Abiomed 14Fr Low Profile Introducer?

According to the FDA alert, it is a catheter introducer kit. The 14Fr refers to the catheter’s diameter measurement.

What is the main concern?

The FDA alert states that prolonged use may lead to thrombus formation.

Where can I find more information?

The complete FDA early alert is available on the FDA’s medical device recalls and early alerts webpage.

The FDA’s early alert system provides important safety communications for healthcare providers and patients regarding medical device issues.

Source: Early Alert: Catheter Introducer Kit Issue from Abiomed

Was this article helpful?

Disclaimer. This article is health journalism intended for general information and education. It is not medical advice and is not a substitute for professional diagnosis or treatment. Always consult a qualified healthcare provider about your individual circumstances. Full disclaimer →

Related Coverage

UK Health Security Agency Updates Vaccination Guidelines for Incomplete Immunisation RecordsJun 13, 2026
Turks and Caicos Becomes Third Caribbean Territory to Eliminate HIV Mother-to-Child TransmissionJun 13, 2026
PAHO Urges Hurricane Preparedness Despite Below-Normal 2026 Season ForecastJun 13, 2026
UK Medicine Broker Registry Updated to Strengthen Drug Supply Chain OversightJun 13, 2026
PG
Written by
Prof. Giorgi Pkhakadze, MD, MPH, PhD
Editor-in-Chief, GMJ News
Full profile →
Medical disclaimer. This article is health journalism intended for general information. It is not medical advice and is not a substitute for consultation with a qualified healthcare professional. Always seek your physician's advice regarding any medical condition.
Medically reviewed by Prof. Giorgi Pkhakadze, MD, MPH, PhD. Spotted an error? Contact the editorial team.
Get the GMJ News digest
Evidence-based health journalism in your inbox. No spam; unsubscribe anytime.
TAGGED:catheter complicationsFDA alertmedical device safetythrombus formationvascular access
Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByGMJ Policy Desk
Follow:
GMJ Policy Desk is part of GMJ News, the newsroom of the Georgian Medical Journal (gmj.ge), published by the Public Health Institute of Georgia. Every article is editorially reviewed before publication.
Leave a Comment Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
UK Health Security Agency Updates Vaccination Guidelines for Incomplete Immunisation Records

UK Health Security Agency issues comprehensive vaccination guidance for patients with incomplete…

Turks and Caicos Becomes Third Caribbean Territory to Eliminate HIV Mother-to-Child Transmission

WHO certifies Turks and Caicos Islands for eliminating mother-to-child transmission of HIV…

PAHO Urges Hurricane Preparedness Despite Below-Normal 2026 Season Forecast

PAHO urges continued hurricane preparedness across the Americas despite below-normal 2026 season…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Pharmaceutical pricing policy timeline showing Trump administration drug pricing deal milestones
Health PolicyPolicy & Systems

Trump Drug Pricing Deals Face First Test as New Medications Launch

By
GMJ Policy Desk
28/05/2026
Medical professionals reviewing AI algorithm data on computer screens in clinical setting
Health PolicyPolicy & Systems

Utah’s AI Sandbox Demonstrates Independent Oversight Model for Clinical AI

By
GMJ Policy Desk
04/06/2026
Infographic showing animal health funding represents tiny fraction of global health spending
Global HealthPolicy & Systems

Animal health receives just 0.6% of global health spending despite mounting disease crises

By
GMJ Policy Desk
27/05/2026
Medical professional discussing prostate cancer screening with patient, representing expanded access to healthcare
Clinical UpdatesHealth PolicyPolicy & SystemsPractice

UK Expands Prostate Cancer Screening Trial to Include More Black Men at Higher Risk

By
GMJ Practice Desk
02/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up